CA2295389C - Methode de traitement de la nausee, du vomissement et d'autres troubles au moyen d'oestrogene - Google Patents

Methode de traitement de la nausee, du vomissement et d'autres troubles au moyen d'oestrogene Download PDF

Info

Publication number
CA2295389C
CA2295389C CA002295389A CA2295389A CA2295389C CA 2295389 C CA2295389 C CA 2295389C CA 002295389 A CA002295389 A CA 002295389A CA 2295389 A CA2295389 A CA 2295389A CA 2295389 C CA2295389 C CA 2295389C
Authority
CA
Canada
Prior art keywords
estrone
vomiting
nausea
receptor
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002295389A
Other languages
English (en)
Other versions
CA2295389A1 (fr
Inventor
Joy Ann Steele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002295389A priority Critical patent/CA2295389C/fr
Publication of CA2295389A1 publication Critical patent/CA2295389A1/fr
Application granted granted Critical
Publication of CA2295389C publication Critical patent/CA2295389C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
CA002295389A 2000-01-04 2000-01-04 Methode de traitement de la nausee, du vomissement et d'autres troubles au moyen d'oestrogene Expired - Lifetime CA2295389C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002295389A CA2295389C (fr) 2000-01-04 2000-01-04 Methode de traitement de la nausee, du vomissement et d'autres troubles au moyen d'oestrogene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002295389A CA2295389C (fr) 2000-01-04 2000-01-04 Methode de traitement de la nausee, du vomissement et d'autres troubles au moyen d'oestrogene

Publications (2)

Publication Number Publication Date
CA2295389A1 CA2295389A1 (fr) 2001-07-04
CA2295389C true CA2295389C (fr) 2006-07-11

Family

ID=4165054

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002295389A Expired - Lifetime CA2295389C (fr) 2000-01-04 2000-01-04 Methode de traitement de la nausee, du vomissement et d'autres troubles au moyen d'oestrogene

Country Status (1)

Country Link
CA (1) CA2295389C (fr)

Also Published As

Publication number Publication date
CA2295389A1 (fr) 2001-07-04

Similar Documents

Publication Publication Date Title
RU2123335C1 (ru) Средство для снижения содержания холестерина в крови, фармацевтическая композиция
US8426394B2 (en) Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etc
DE69022722T2 (de) Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen.
DE60216630T2 (de) Verwendung von östrogen in kombination mit progestogen für die hormonsubstitutiionstherapie
TWI359015B (en) Pharmaceutical composition for treatment or preve
RU2157203C2 (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования эндометриоза
US9616074B2 (en) Compositions and methods for suppressing endometrial proliferation
SK622004A3 (en) Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
JP2002087992A (ja) 白内障治療用組成物及び方法
US7256185B1 (en) Control of selective estrogen receptor modulators
EP1703910A2 (fr) Traitement de l'osteoporose liee a la therapie par un inhibiteur de l'aromatase
TW201031400A (en) Trans-clomiphene for metabolic syndrome and diabetes mellitus type 2
US6239122B1 (en) Method of treatment of nausea, vomiting, and other disorders using estrogens
US20030181431A1 (en) Control of selective estrogen receptor modulators
JP2005531575A (ja) チボロンおよびｓｅｒｍを含む、乳癌患者における後−閉経期障害の治療
JP2006504666A (ja) デヒドロエピアンドロステロン・ステロイド及び抗ムスカリン薬で呼吸器及び肺の疾患を治療するための組成物、配合物及びキット
CA2295389C (fr) Methode de traitement de la nausee, du vomissement et d'autres troubles au moyen d'oestrogene
US20090118253A1 (en) Compositions and methods for treating dysfunctional uterine bleeding
JPH07215866A (ja) 男性不妊症を抑制する方法
JP2003513908A (ja) ホルモン補充療法（ｈｒｔ）のための組成物の成分としてのメソプロゲスチン（プロゲステロン受容体モジュレーター）
EP1078630A1 (fr) Utilisation des agonistes de récepteur sigma pour le traitement de la dépression
TWI293251B (en) Selective estrogen receptor modulators incombination with estrogens
Rousseau Selected Hormonal Agents in Gynecology
KR20180112048A (ko) 클로미펜 이성질체들의 경구 제형 및 이차 생식선 기능저하증 치료를 위하여 이들을 사용하는 방법
JP2000159688A (ja) 子宮内膜症の処置又は予防剤

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20200106